Corporate Finance

Online broker PU Prime partners with Argentina's AFA for a new campaign, but can a human-centric message overcome industry skepticism and user complaints?

The Chinese construction giant is transforming Serbia's infrastructure with a new ESG focus, but a look beyond the concrete reveals a complex picture.

Samsung Bioepis is now directly selling its Lucentis biosimilar in Europe, a move set to increase competition and improve access to vital eye disease treatments.

Robert Larsson takes the helm at ventilation giant Systemair, tasked with an aggressive strategy to double the company's size by 2033. Can he succeed?

Chinese auto giant GAC nearly tripled its exports in two years. Its secret? A hyper-localized strategy that is challenging incumbents worldwide.

Supermicro's new liquid-cooled 6U SuperBlade packs 100 servers per rack, powered by Intel Xeon 6900 CPUs to tackle the most demanding AI & HPC workloads.

South Korea's KLMBio is accelerating its global push with major investments in production and new products to capture the booming regenerative medicine market.

NAVER D2SF invests in Sorcerics, a startup whose proactive AI and on-device processing promise a smarter, safer, and more affordable smart home future.

A 16-year-old's 'Reappearance Protocol' has placed 39 acid attack survivors in jobs with an 80% retention rate, setting a new standard in India.

ASUS sets the stage for CES 2026 with a dual-screen Zenbook DUO and a durable ProArt laptop co-engineered with GoPro, all powered by a new AI vision.

DAREU is set to unveil three high-performance peripherals at CES 2026, combining advanced magnetic switches with an aggressive global expansion strategy.

The revered former U.S. Senator announced his withdrawal from public life following a dementia diagnosis, ending a storied career and sparking reflection.

A recent broadcast raised $5.2M for St. Jude, showcasing the power of Hispanic media and community philanthropy in the fight against childhood cancer.

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

Privately held MMMera hires strategic firm CND-SA to scale its Guillotine® gaming IP, a move highlighting the high-stakes game of professionalizing art.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

The investment firm renews its plan to repurchase up to 5% of its units, signaling a strong belief that its market price is below its intrinsic value.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

Emmaus Life Sciences outsources its sickle cell drug Endari® in North America to focus on global growth, as NeoImmuneTech gains a key U.S. market foothold.